期刊文献+

原发肢体软组织肉瘤208例预后的影响因素分析 被引量:4

Retrospective analysis and prognostic factors of 208 cases of primary soft tissue sarcoma of extremity
原文传递
导出
摘要 目的 探讨影响肢体软组织肉瘤预后的因素,特别是外科治疗对其预后的影响.方法 回顾性研究208例手术治疗的肢体软组织肉瘤患者,其中男性128例,女性80例,平均年龄46岁(9~98)岁.分析患者是否初治、肿瘤的大小(<5 cm、5~10 crn、>10 cm)、深度(深筋膜深层、浅层)、组织学分型(脂肪肉瘤、恶性纤维组织细胞瘤、滑膜肉瘤、纤维肉瘤、恶性神经鞘瘤、其他肿瘤)、病理分级(FNCLCC系统Ⅰ、Ⅱ、Ⅲ级)、外科边界(囊内切除、边缘切除、广泛切除、根治切除)以及辅助治疗等因素对患者预后的影响.结果 中位随访时间37.5个月(1.3 ~ 128.1个月),总体3年、5年生存率77%和75%;复发率28%和37%;转移率35%和43%.肿瘤大小、病理分级和术前是否有转移可以独立影响生存率(x2=18.813、24.849、21.107,均P<0.05);是否为初治病例、组织学分型可以独立影响复发率(x2=21.915、12.192,P<0.05);病理分级可以独立影响转移率(x2=7.714,P<O.05).手术外科边界可以独立影响局部复发率和转移率(x2=19.610、9.272,P<0.05).结论 外科边界独立影响局部复发率和远处转移率,从而间接影响生存率.尤其对无转移的初次治疗的软组织肉瘤,手术是首选方案,手术外科边界达到广泛切除或根治性切除将明显改善患者的预后. Objective To investigate the prognosis factors of soft tissue sarcoma,especially the impact of surgical treatment on the prognosis.Methods We retrospectively reviewed 208 surgically treated patients.There were 128 male and 80 female.The average age was 46 ranged from 9 to 98 years old.Possible factors of whether the patient firstly treated in our hospital,the tumor size ( 〈 5 cm,5 ~ 10 cm,〉 10 cm),tumor depth (superficial deep fascia,under the deep fascia),histological type (such as adipose sarcoma,malignant fibrous histiocytoma,synovial sarcoma,fibrous sarcoma,malignant peripheral nerve sheath tumors,other tumors ),tumor grade (FNCLCC Ⅰ,Ⅱ,Ⅲ ),surgical margin (intralesional,marginal,wide,radical) and adjuvant therapy on the prognosis of patients were analyzed.Results The median follow-up was 37.5 ranged from 1.3 to 128.1 months.The overall 3-year and 5-year survival were 77% and 75%.The overall 3-year and 5-year recurrence rate were 28% and 37%.The overall 3-year and 5-year metastasis rate were 35% and 43%.Tumor size,tumor grade and metastasis or not independently affected survival (x2 =18.813,24.849 and 21.107,all P 〈0.05).Whether the patient firstly treated in our hospital and histological type independently affect the local recurrence (x2 =21.915,12.192,both P 〈0.05 ) ; histological grade can independently affect the metastasis ( x2 =7.714,P 〈 0.05 ).Surgical margin alone affected the local recurrence and metastasis (x2 =19.610,9.272,both P 〈0.05).Conclusions Surgical margin independently affected local recurrence and distant metastasis,and thus indirectly affect the survival of soft tissue sarcoma.In particular,the primary choice for treatment of soft tissue sarcoma without metastasis should be surgery.Wide or radical margin could significantly improve the prognosis of soft tissue sarcoma patients.
出处 《中华外科杂志》 CAS CSCD 北大核心 2011年第11期964-969,共6页 Chinese Journal of Surgery
基金 首都医学发展科研基金资助项目(2009-3096)
关键词 肉瘤 软组织 治疗 预后 Sarcoma, soft tissue Treatment Prognosis
  • 相关文献

参考文献16

  • 1Trojani M,Contesso G,Coindre JM,et al.Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system.Int J Cancer,1984,33:37-42.
  • 2Enneking WF.A system of staging musculoskeletal neoplasms.Clin Orthop Relat Res,1986 (204):9-24.
  • 3Cho HS,Park IH,Jeong W J,et al.Prognostic value of computed tomography for monitoring pulmonary metastases in soft tissue sarcoma patients after surgical management:A Retrospective Cohort Study[published online ahead of print May 3,2011].Ann Surg Oncol,2011,http://www.springerlink.com/content/v102171 w54jr4522/.
  • 4Garcia-Del-Muro X,López-Pousa A,Maurel J,et al.Randomized phase Ⅱ study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma:a Spanish Group for Research on Sarcomas Study.J Clin Oncol,2011,29:2528-2533.
  • 5Penel N,Glabbeke MV,Mathoulin-Pelissier S,et al.Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma:the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study.Br J Cancer,2011,104:1544-1550.
  • 6Brennan MF.The enigma of local recurrence.The Society of Surgical Oncology.Ann Surg Oncol,1997,4:1-12.
  • 7Pisters PW,Leung DH,Woodruff J,et al.Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.J Clin Oncol,1996,14:1679-1689.
  • 8Singer S,Corson JM,Gonin R,et al.Prognostic factors prodictive of survival and local recurrence for extremity soft tissue sarcoma.Ann Surg,1994,219:165-173.
  • 9Stoeckle E,Gardet H,Coindre JM,et al.Prospective evaluation of quality of surgery in soft tissue sarcoma.Eur J Surg Oncol,2006,32:1242-1248.
  • 10Gronchi A,Miceli R,Fioro M,et al.Extremity soft tissue sarcoma:adding to the prognostic meaning of local failure.Ann Surg Oncol,2007,14:1583-1590.

二级参考文献25

  • 1Lewis JJ,Leung D,Espat J,et al.Effect of reresection in extremity soft tissue sarcoma[J].Ann Surg,2000,231(5):655-663.
  • 2Nijhuis PH,Schaapveld M,Otter R,et al.Epidemiological aspeels of soft tissue sarcomas (STS)-consequences for the design of clinical STS trials[J].Eur J Cancer,1999,35(12):1705-1710.
  • 3Billingsley KG,Lewis JJ,Leung DH,et al.Multifaetorial analysis of the survival of patients with distant metastasis arisifig from primary extremity sarcoma[J].Cancer,1999,85(2):389-395.
  • 4van Geel AN,Pastorino U,Jauch KW,et al.Surgical treatment of lung metastases:the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients[J].Cancer,1996,77(4):675-682.
  • 5Billingsley KG,Burt ME,Jara E,et al.Pulmonary metastases from soft tissue sarcoma:analysis of patterns of diseases and postmetastasis survival[J].Ann Surg,1999,229(5):602-610.
  • 6van Geel AN,Hoekstra HJ,van Coevorden F,et al.Repeated resection of recurrent pulmonary metastatic soft tissue sarcoma[J].Eur J Surg Oncol,1994,20(4):436-440.
  • 7Coindre JM,Terrier P,Guillou L,et al.Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas:a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group[J].Cancer.2001,91(10):1914-1926.
  • 8Hoos A,Lewis JJ,Brennan MF.Soft tissue sarcoma:prognostic factors and multimodal treatment[J].Chirurg,2000,71(7):787-794.
  • 9Ham SJ,van der Graaf WT,Pras E,et al.Soft tissue sarcoma of the extremities:A multimodality diagnostic and therapeutic approach[J].Cane Trea Rev,1998,24(6):373-391.
  • 10Simon MA,Enneking WF.The management of soft tissue sarcomas of the extremities[J].J Bone Joint Surg,1976,58A(3):317-327.

共引文献7

同被引文献37

  • 1Nedea EA, DeLaney TF. Sarcoma and skin radiation oncology[J]. Hematol Oncol Clin North Am, 2006, 20(2):401-429.
  • 2Fiore M, Casali PG, Miceli R, et al. Prognostic effect of re-excision in adult soft tissue sarcoma of the extremity[J]. Ann Surg Oncol 2006, 13:110-117.
  • 3Chandrasekar CR, Wafa H, Grimer RJ, et al. The effect of un- planned excision of a soft tissue sarcoma on prognosis[J]. The Jour- nal of Bone and.Toint Surgery(Br), 2008, 90:203-208.
  • 4Kang S, Han I, Lee SA, et al. Unplanned excision of soft dssue sar- coma: the impact of the referring hospital[J]. Surgical Oncology, 2013, 22(2):17-22.
  • 5Borby K, Nmeth Z, Ktsler M. Clinical application of 18F-FDG PET / CT in the treatment of sarcomas [J]. Magy Onkol, 2014, 58 (1):24-31.
  • 6Mendenhall WM, Indelicato D J, Searborough MT, et al. The management of adult soft tissue sarcomas [J] .Am J Clin Oncol, 2009, 32(4 ) :436-442.
  • 7Kang S, Kim HS, Kim S, et al. Post-metastasis survival in extremity soft tissue sarcoma: a recursive partitioning analysis of prognostic factors [J]. Eur J Cancer, 2014, 50 ( 9 ): 1649-1656.
  • 8Andreou D, Boldt H, Pink D, et al. Prognostic relevance of 18F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF- a and melphalan [J]. Eur J Nnel Med Mol Imaging, 2014, 41 ( 6 ) : 1076-1083.
  • 9Ueda S, Tsuda H, Saeki T, et al. Early metabolic response to neoadjuvant letrozole, measured by FDG PET / CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone receptor-positive primary breast cancer: a pilot study [J]. Breast Cancer, 2011, 18 (4): 299-308.
  • 10Bai B, Huang HQ, Cai Qc, et al. Predictive value of pretreatment positron emission tomography / computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma [J]. Med Oncol, 2013, 30( 1 ) : 339.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部